A Practical Research Agenda for Treatment Development for Stimulant Use Disorder

The Reagan-Udall Foundation for the FDA, in collaboration with the FDA and the National Institute on Drug Abuse, hosted a virtual public workshop titled A Practical Research Agenda for Treatment Development for Stimulant Use Disorder. This report summarizes discussions from the workshop where experts examined evidence for candidate endpoints and study design strategies for clinical trials of stimulant use disorder treatments.